Insider Transactions
| Date
|
Name
|
Title
|
Type
|
Shares Traded
|
Price Range
|
| May 21, 2013 |
Bourne, George W. IV |
Officer |
Disposition (Non Open Market) |
948 |
10.96 |
| May 9, 2013 |
Greiner, Charles |
Officer |
Sell |
1,495 |
10.38 |
| Mar 25, 2013 |
Gold, Jeffrey |
Director |
Option Execute |
2,508 |
6.52 |
| Mar 12, 2013 |
Bucci, Vincent |
Director |
Buy |
40,000 |
10.78 |
| Mar 12, 2013 |
Bucci, Vincent |
Director |
Buy |
45,000 |
10.76
- 10.80 |
| Mar 12, 2013 |
Meteny, Dennis |
Director |
Buy |
4,600 |
10.82 |
| Feb 14, 2013 |
Bucci, Vincent |
Director |
Buy |
2,000 |
12.17 |
| Feb 1, 2013 |
Frost, Mark |
Officer |
Acquisition (Non Open Market) |
20,000 |
n/a
|
| Jan 28, 2013 |
Mcgill, Stephen |
Officer |
Disposition (Non Open Market) |
2,600 |
12.35 |
| Jan 28, 2013 |
Richard, Stark |
Officer |
Disposition (Non Open Market) |
838 |
12.35 |
| Jan 11, 2013 |
Gould, Kevin |
Director |
Buy |
2,700 |
11.58 |
| Dec 17, 2012 |
Bourne, George W. IV |
Officer |
Acquisition (Non Open Market) |
2,000 |
n/a
|
| Nov 15, 2012 |
Kapusta, Matthew |
Officer |
Disposition (Non Open Market) |
1,358 |
10.12 |
| Nov 5, 2012 |
Gold, Jeffrey |
Director |
Buy |
1,000 |
10.56 |
| Nov 5, 2012 |
Richard, Stark |
Officer |
Sell |
3,160 |
10.36 |
| Oct 26, 2012 |
Greiner, Charles |
Officer |
Statement of Ownership |
0 |
n/a
|
| Oct 23, 2012 |
Soto, John |
Officer |
Acquisition (Non Open Market) |
10,000 |
n/a
|
| Sep 7, 2012 |
Devivo, Joseph |
Officer |
Disposition (Non Open Market) |
2,526 |
12.12 |
| Sep 4, 2012 |
Gersuk, Joseph |
Officer |
Disposition (Non Open Market) |
1,086 |
11.61 |
| Sep 4, 2012 |
Richard, Stark |
Officer |
Disposition (Non Open Market) |
715 |
11.61 |
|
Stock transaction information provided by EDGAR Online. AngioDynamics makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
